DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bydureon (Exenatide) - Current Clinical Trials

 
 



Bydureon Related Clinical Trials

Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1) [Completed]

Trial of Exenatide for Parkinson's Disease [Active, not recruiting]

The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females [Completed]

Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes [Completed]

Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes [Active, not recruiting]

Pharmacology of Exenatide in Pediatric Sepsis [Withdrawn]

A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes [Completed]

Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes [Recruiting]

Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms [Completed]

Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy [Completed]

Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function [Completed]

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus [Completed]

New Onset Type 1 Diabetes: Role of Exenatide [Recruiting]

A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension [Completed]

Safety and Efficacy of Exenatide as Monotherapy [Completed]

Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease [Terminated]

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin [Completed]

Bioenergetic Alterations After Exenatide Administration [Completed]

Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus [Recruiting]

Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus [Completed]

Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes [Active, not recruiting]

The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes [Completed]

Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome [Active, not recruiting]

Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults [Completed]

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes [Completed]

Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes [Suspended]

The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes [Recruiting]

The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes [Completed]

A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes [Completed]

Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying [Active, not recruiting]

Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes [Completed]

Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus [Completed]

Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes [Withdrawn]

Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial) [Recruiting]

Exenatide in Extreme Pediatric Obesity [Completed]

Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes [Completed]

Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination [Completed]

Exenatide for Myocardial Protection During Reperfusion Study [Recruiting]

Exenatide for Stress Hyperglycemia [Recruiting]

Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta«) Therapy for the Inpatient Management of Patients With Type 2 Diabetes [Not yet recruiting]

Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults [Completed]

A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension [Completed]

The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects [Recruiting]

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin [Completed]

Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes [Completed]

A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide [Completed]

Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus [Recruiting]

Exeantide in Type 2 Diabetes on Insulin [Completed]

An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus [Completed]

Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes [Completed]

Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes [Recruiting]

Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome [Withdrawn]

Exenatide and Weight Loss for Diabetes Prevention [Completed]

A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes [Completed]

Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease [Completed]

Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes [Completed]

A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus [Completed]

Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight [Active, not recruiting]

Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome [Active, not recruiting]

Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure [Completed]

The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients [Recruiting]

Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM [Not yet recruiting]

Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes [Recruiting]

Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist [Recruiting]

Effect of Exenatide on Liver and Heart Fat and Inflammation [Completed]

Evaluation of Exenatide in Patients With Diabetic Neuropathy [Completed]

Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment [Completed]

Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure [Terminated]

Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients [Completed]

Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes [Not yet recruiting]

Exenatide (Byetta) Versus Pramlintide (Symlin): Role in Post-Prandial Hyperglycemia [Enrolling by invitation]

How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics [Completed]

Effect of Exenatide, Sitagliptin or Glimepiride on Functional ├č -Cell Mass [Completed]

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin [Completed]

Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes [Completed]

Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes [Completed]

An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus [Completed]

Intravenous Exenatide (Byetta) During Surgery [Recruiting]

A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects [Completed]

A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes [Completed]

Exenatide Versus Glimepiride in Patients With Type 2 Diabetes [Completed]

Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes [Recruiting]

Impact of Exenatide on Sleep in Type 2 Diabetes [Recruiting]

Effect on Weight Loss of Exenatide Versus Placebo [Completed]

Effect of Exenatide on Brain, Adipose Tissue, Pancreas, and Liver Function [Active, not recruiting]

A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon«) on Glucose Control in Patients With Type I Diabetes [Recruiting]

Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s) [Completed]

Safety and Efficacy of Exenatide Injection in Subjects With Type 2 Diabetes Mellitus [Recruiting]

Intravenous Exenatide in Patients With Acute Brain Injury [Not yet recruiting]

A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650 [Active, not recruiting]

Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor [Completed]

GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin [Completed]

A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes [Withdrawn]

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes [Completed]

Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017